首页 | 官方网站   微博 | 高级检索  
     

昂立明视胶囊抗白内障的动物试验
引用本文:李慈娟,范小兵,韩超,张迪,杨彬,吴晓兰.昂立明视胶囊抗白内障的动物试验[J].中成药,2001,23(3):199-201.
作者姓名:李慈娟  范小兵  韩超  张迪  杨彬  吴晓兰
作者单位:1. 上海交大昂立生物医药研究所,上海,200030
2. 江苏省药物研究所,江苏,南京,210009
摘    要:目的:观察昂立明视胶囊对实验性白内障的预防和治疗作用。方法:使用D-半乳糖制作大白鼠眼折内障模型,检查了昂立明视胶囊对大鼠眼晶体白内障进展、浑浊度、晶体纤维超微结构、MDA、不溶性蛋白和高分子蛋白含量的影响。结果:服用昂立明视胶囊能有效地延缓受试大鼠白内障的进展,降低晶体混浊度,减轻D-半乳糖对大鼠晶体纤维超微结构的损伤;生化指标也显示该品能降低晶体MDA的含量,减轻晶体脂质过氧化损伤,降低晶体内不溶性蛋白和高分子量蛋白的含量。结论:昂立明视胶囊具有改善视力的作用。

关 键 词:昂立明视胶囊  白内障  晶体浑浊度  中医药治疗  动物实验
文章编号:1001-1528(2001)03-0199-03
修稿时间:2000年10月20

Anti-catarct Animal Test of Anglimingshi Capsules
LI Ci juan ,FAN Xiao bing ,HAN Chao ,ZHANG Di ,YANG Bin ,WU Xiao lan.Anti-catarct Animal Test of Anglimingshi Capsules[J].Chinese Traditional Patent Medicine,2001,23(3):199-201.
Authors:LI Ci juan  FAN Xiao bing  HAN Chao  ZHANG Di  YANG Bin  WU Xiao lan
Affiliation:LI Ci juan 1,FAN Xiao bing 1,HAN Chao 1,ZHANG Di 1,YANG Bin 2,WU Xiao lan 2
Abstract:Objective: To investigate the effects of Anglimingshi Capsules on preventing and treating experimental catarct. Methods: The model of D galactose induced catarct in rats was established. The effects of Anglimingshi Capsules on the catarct advance, lens opacity, lens structure, MDA and the concentrations of disoluble protein and high weight protein of treated rats were examined.Results: Anglimingshi Capsules could delay the advance of catarct, lower lens opacity and lighten the injury of lens structure by D galactose. Anglimingshi Capsules also decreased the concentration of MDA, lightened the injury of lens by lipid peroxidation and decreaseed the concentrations of disoluble protein and high weight protein. Conclusion: The test provided the foundation for application of Anglimingshi capsule.
Keywords:Anglimingshi Capsules  catarct  lens opacity  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号